COMPARE · Data as of August 27, 2026
EXR vs IIPR
Verdict: Side-by-side breakdown using the Bull Rankings model. EXR scored 70.0, IIPR scored 64.0 — EXR leads.
Compare another set
Different reporting periods. IIPR's fundamentals are as of June 2026, but EXR's are as of March 2026 — a 3-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
EXR
Extra Space Storage Inc.
65.5Fin
$142.79 · $31.5B
fundamentals as of
Strength gap
2.7
IIPR leads
IIPR
Innovative Industrial Properties, Inc.
68.2Fin
$56.42 · $1.6B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- Fastest growthEXR+3.7%
- Strongest balance sheetIIPR0.33
Side by side · every name on one set of axes
Fundamentals, head-to-head
EXR
IIPR
4.5%B+
Yield
13.3%C+
+3.7%C+
Rev
-13.8%D
1.02B
D/E
0.33A
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
EXRExtra Space Storage Inc.
Why now
REIT - Industrial · market cap $31.5b. 10% off the 52-week high of $158.88. 20 sell-side analysts rate this a Buy with a mean 1-yr target of $158.20 (implying +11% upside).
Moat
Net margin 27% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close.
Risk
Dividend payout 143% of earnings on a 4.5% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. ROE 7% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
IIPRInnovative Industrial Properties, Inc.
Why now
REIT - Industrial · market cap $1.6b. 14% off the 52-week high of $65.38. Revenue -14% — in contraction; any catalyst that reverses this triggers re-rating. 4 sell-side analysts rate this a Hold with a mean 1-yr target of $64.50 (implying +14% upside).
Moat
Net margin 52% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma.
Risk
Revenue contracting -14% — the operational turn is not yet visible in the top line. Beta 1.40 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. Dividend payout 172% of earnings on a 13.3% yield — distribution coverage is thin; one earnings stumble could force a dividend cut.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.